Correction: Cofilin drives cell-invasive and metastatic responses to TGF-B in prostate cancer (Cancer Res (2014) 74 (2362–2373) DOI: 10.1158/0008-5472.CAN-13-3058);Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer

Cancer Research

Volumn 74, Issue 8, 2014, Pages 2362-2373

  Collazo, Joanne ^a   Zhu, Beibei ^a   Larkin, Spencer ^a   Martin, Sarah K ^a   Pu, Hong ^a   Horbinski, Craig ^a   Koochekpour, Shahriar ^b   Kyprianou, Natasha ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COFILIN; LIM KINASE; LIM KINASE 2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; CYTOSKELETON; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG METASTASIS; MALE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; TUMOR MICROENVIRONMENT;

ACTIN DEPOLYMERIZING FACTORS; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE MODELS, ANIMAL; HETEROGRAFTS; HUMANS; MALE; MICE; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84899538936     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-18-1845     Document Type: Erratum

References (50)

1. Arnold J, Isaacs JT. Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault. Endocr Relat Cancer 2002;9:61-73.
2. Catalona WJ. Management of cancer of the prostate. N Engl J Med 1994;331:996-1004.
3. McKenzie S, Kyprianou N. Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance. J Cell Biochem 2006;97:18-32.
4. Karantanos T, Thompson TC. GEMMS shine a light on resistance to androgen deprivation therapy for prostate cancer. Cancer Cell 2013; 24:11-3.
5. Lunardi A, Ala U, Epping MT, Salmera L, Clohessy JG, Webster KA, et al. A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nat Genetics 2013;45:747-55.
6. Tuxhorn JA, Ayala GE, Smith MG, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: Induction ofmyofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002; 8:2912-23.
7. Yang F, Strand DW, Rowley DR. Fibroblast growth factor-2 mediates transforming growth factor-b action in prostate cancer reactive stroma. Oncogene 2007;27:450-9.
8. Desmouliere A, Guyot C, Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 2004;48:509-17.
9. Olsen CJ, Moreira J. Lukanidin EM, Ambartsumian NS. Human mammary fibroblasts stimulate invasion of breast cancer cells in a threedimensional culture and increase stroma development in mouse xenografts. BMC Cancer 2010;10:444-60.
10. Yin M, Soikkeli J, Jankola T, Virolainen S, Saksela O, Holtta E. TGF-b signaling, activated stromal fibroblasts and cysteine cathepsins B and L drive the invasive growth of human melanoma cells. Am J Pathol 2011;181:2202-15.
11. Nasu Y, Timme TL, Yang G, Bangma CH, Li L, Ren C, et al. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nat Med 1998;4: 1062-4.
12. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 1996;12:895-904.
13. Goel H, Li J, Kogan S, Languino LR. Integrins in prostate cancer progression. Endocr Relat Cancer 2008;15:657-64.
14. Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T, et al. Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med 2010; 16:1414-20.
15. Sakamoto S, Kyprianou N. Targeting anoikis resistance in prostate cancer metastasis. J Mol Aspects Med 2010;31:205-14.
16. Kumar J, Park S-H, Cieply B, Shupp J, Killiam E. A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition. Mol Cell Biol 2011;31:4036-51.
17. Condeelis JS, Singer RH, Segall J. The great escape: when cancer cells hijack the genes for chemotaxis and motility. Annu Rev Cell Dev Biol 2005;21:695-718.
18. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006;127:679-95.
19. Davila M, Frost AR, Grizzle WE, Chakrabarti R. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem 2003;278: 36868-75.
20. Ono S. Mechanism of depolymerization and severing of actin filaments and its significance in cytoskeletal dynamics. Int Rev Cytol 2007; 258:1-82.
21. Lee SH, Dominguez R. Regulation of actin cytoskeleton dynamics in cells. Mol Cell 2010;29:311-25.
22. Yilmaz M, Christofori G. Mechanisms of motility in metastasizing cells. Mol Cancer Res 2010;8:629-42.
23. Chen J, Godt D, Gunsalus K, Kiss I, Goldberg M, Laski FA. Cofilin/ADF is required for cell motility during Drosophila ovary development and oogenesis. Nat Cell Biol 2001;3:204-9.
24. Ghosh M, Song X, Mouneimne G, Sidani M, Lawrence DS, Condeelis JS. Cofilin promotes actin polymerization and defines the direction of cell motility. Science 2004;304:743-6.
25. DesMarais V, Sidani M, Scemes E, Wang W, Song X, Eddy R, et al. Spatial and temporal control of cofilin activity is required for directional sensing during chemotaxis. Curr Biol 2006;16: 2193-205.
26. Van Troys M, Huyck L, Leyman S, Dhaese S, Vandekerkhove J, Ampe C. Ins and outs of ADF/cofilin activity and regulation. Eur J Cell Biol 2008;87:649-67.
27. Hotulainen P, Paunola E, Vartiainen MK, Lappalainen P. Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-Actin depolymerization in mammalian nonmuscle cells. Mol Biol Cell 2005;16:649-64.
28. Hall A. Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu Rev Cell Biol 1994;10:31-54.
29. Olson MF. Applications for ROCK kinase inhibition. Curr Opin Cell Biol 2008;20:242-8.
30. Oleinik NV, Krupenko NI, Krupenko SA. ALDH1L1 inhibits cell motility via dephosphorylation of cofilin by PP1 and PP2A. Oncogene 2010;25: 6233-44.
31. JakowlewSB. Transforming growth factor-b in cancer and metastasis. Cancer Metastasis Rev 2006;25:435-57.
32. Teicher BA. Transforming growth factor-beta and the immune response to malignant disease. Clin Cancer Res 2007;13:6247-51.
33. Pu H, Collazo J, Jones E, Gayheart D, Sakamoto S, Vogt A, et al. Dysfunctional TGF-b receptor II accelerates prostate tumorigenesis in the TRAMP mouse model. Cancer Res 2009;69:7366-74.
34. Guo Y, Kyprianou N. Overexpression of transforming growth factor (TGF)-b1 type II receptor, restores TGF-b1-sensitivity and signaling in human prostate cancer cells, LNCaP. Cell Growth and Differentiation 1998;9:185-93.
35. Bello-Deocampo D, Tindall DJ. TGF-b/Smad signaling in prostate cancer. Curr Drug Targets 2003;4:197-207.
36. Massague J. TGF b in Cancer. Cell 2008;25:215-30.
37. Micalizzi DS, Wang CA, Farabaugh SM, Schiemann WP, Ford HL. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth. Cancer Res 2010;1570:10371-80.
38. Zhu B, Fukada K, Zhu H, Kyprianou N. Prohibitin and cofilin are intracellular effectors of transforming growth factor-b signaling in human prostate cancer cells. Cancer Res 2006;66:8640-77.
39. Yang F, Strand DW, Rowley DR. Fibroblast growth factor-2 mediates transforming growth factor-b action in prostate cancer reactive stroma. Oncogene 2007;27:450-9.
40. Jung Y, Kim JK, Shiozawa Y, Wang J, Mishra A, Joseph J, et al. Recruitment of mesenchymal stem cells into prostate tumors promotes metastasis. Nat Commun 2013;4:1795-805.
41. Arjonen A, Kaukonen R, Ivaska J. Filopodia and adhesion in cancer cell motility. Cell Adh Migr 2011;5:421-30.
42. Zhu H, Zhao J, Zhu B, Collazo J, Gal J, Shi P, et al. EMMPRIN regulates cytoskeleton reorganization and prostate cancer cell invasion. Prostate 2012;72:72-81.
43. Zebda N, Bernard O, Bailly M, Welti S, Lawrence DS, Condeelis JS. Phosphorylation of ADF/cofilin abolishes EGF-induced actin nucleation at the leading edge and subsequent lamellipodia extension. J Cell Biol 2000;27:1119-28.
44. Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ, et al. Autonomic nerve development contributes to prostate cancer metastasis. Science 2013;341:361-7.
45. Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, Makris A, et al. The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol 2006; 8:395-404.
46. Wang W, Eddy R, Condeelis JS. The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 2007;7:429-40.
47. Nishimura S, Tsuda H, Kataoka F, Arao T, Nomura H, Chiyoda T, et al. Overexpression of cofilin 1 can predict progression-free survival in patients with epithelial ovarian cancer receiving standard therapy. Human Pathol 2011;42:516-21.
48. Popow-Wozniak A, Mazur AJ, Mannherz HG, Malicka-Bøaszkiewicz M, Nowak D. Cofilin overexpression affects actin cytoskeleton organization and migration of human colon adenocarcinoma cells. Histochem Cell Biol 2012;138:725-36.
49. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate. Cancer Res 1992;52:5104-10.
50. Caino CM, Chae YC, Vaira V, Ferrero S, Nosotti M, Martin NM, et al. Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells. J Clin Invest 2013;123:2907-20.